Contrasting Omnicell Technologies (OMCL) and Dell Technologies (DVMT)

Omnicell Technologies (NASDAQ: OMCL) and Dell Technologies (NYSE:DVMT) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends and institutional ownership.

Volatility and Risk

How to Become a New Pot Stock Millionaire

Omnicell Technologies has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500. Comparatively, Dell Technologies has a beta of -0.49, indicating that its share price is 149% less volatile than the S&P 500.

Institutional and Insider Ownership

23.1% of Dell Technologies shares are owned by institutional investors. 3.7% of Omnicell Technologies shares are owned by insiders. Comparatively, 45.0% of Dell Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Omnicell Technologies and Dell Technologies’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Omnicell Technologies $716.16 million 2.40 $20.60 million $0.18 245.83
Dell Technologies $78.66 billion 0.73 -$3.73 billion $6.17 12.15

Omnicell Technologies has higher earnings, but lower revenue than Dell Technologies. Dell Technologies is trading at a lower price-to-earnings ratio than Omnicell Technologies, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent recommendations for Omnicell Technologies and Dell Technologies, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omnicell Technologies 0 2 5 0 2.71
Dell Technologies 0 1 3 0 2.75

Omnicell Technologies currently has a consensus price target of $56.14, suggesting a potential upside of 26.88%. Dell Technologies has a consensus price target of $110.00, suggesting a potential upside of 46.76%. Given Dell Technologies’ stronger consensus rating and higher possible upside, analysts clearly believe Dell Technologies is more favorable than Omnicell Technologies.


This table compares Omnicell Technologies and Dell Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Omnicell Technologies 2.88% 1.54% 0.77%
Dell Technologies -4.74% 23.17% 3.15%


Dell Technologies beats Omnicell Technologies on 8 of the 14 factors compared between the two stocks.

Omnicell Technologies Company Profile

Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates through two segments, Automation and Analytics, and Medication Adherence. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, a software which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Anesthesia Workstation that manages anesthesia supplies and medications. The company also provides XR2 Central Pharmacy System, a hospital pharmacy robotics system; Central and Satellite Pharmacy Manager, an automated pharmacy storage and retrieval system; Controlled Substance Management, a controlled substance inventory management system; OmniLinkRx, a prescription routing system; and WorkflowRx, an automated pharmacy storage, retrieval, and packaging system. In addition, it offers Omnicell Supply Management System, an automated dispensing system; Omnicell Tissue Center, which manages the chain of custody for bone and tissue specimens; OptiFlex MS that manages medical and surgical supplies; OptiFlex SS, a module for the perioperative areas; and OptiFlex CL, a module for the cardiac catheterization lab and other procedure areas. Further, the company provides IV Solutions; enterprise analytics and solutions; Omnicell Interface Software; Mach4 Pharma Systems Medimat, a robotic dispensing system; Omnicell SupplyX subscription software; RFID solutions; and consumable medication blister cards, packaging equipment, and ancillary products and services to institutional pharmacies. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was founded in 1992 and is headquartered in Mountain View, California.

Dell Technologies Company Profile

Dell Technologies Inc., formerly Denali Holding Inc., is a provider of information technology solutions. The Company operates through two segments: Client Solutions and Enterprise Solutions Group (ESG). The Client Solutions segment includes sales to commercial and consumer customers of desktops, thin client products and notebooks, as well as services and third-party software and peripherals closely tied to the sale of Client Solutions hardware. Its offerings include hardware, such as desktop personal computers, notebooks and tablets, and peripherals, such as monitors, printers and projectors, as well as third-party software and peripherals. The ESG segment includes servers, networking and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ESG hardware. It designs, develops, manufactures, markets, sells and supports a range of products and services.

Receive News & Ratings for Omnicell Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell Technologies and related companies with's FREE daily email newsletter.

Leave a Reply